Cargando…
P1417: PROPHYLACTIC NAC PROMOTED HEMATOPOIETIC RECONSTITUTION BY IMPROVING ENDOTHELIAL CELLS AFTER HSCT: A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL
Autores principales: | Wang, Y., Kong, Y., Zhao, H.-Y., Zhang, Y.-Y., Wang, Y.-Z., Xu, L.-P., Zhang, X.-H., Liu, K.-Y., Huang, X.-J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429681/ http://dx.doi.org/10.1097/01.HS9.0000848528.52063.24 |
Ejemplares similares
-
Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial
por: Wang, Yu, et al.
Publicado: (2022) -
A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during the perioperative period of ultrasound-guided transrectal prostate biopsy
por: Qiao, L.-D., et al.
Publicado: (2016) -
Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer
por: He, H, et al.
Publicado: (2014) -
Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study
por: Huo, Y., et al.
Publicado: (2016) -
Endothelial jagged-2 sustains hematopoietic stem and progenitor reconstitution after myelosuppression
por: Guo, Peipei, et al.
Publicado: (2017)